Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.
Feldmann G, Mishra A, Bisht S, Karikari C, Garrido-Laguna I, Rasheed Z, Ottenhof NA, Dadon T, Alvarez H, Fendrich V, Rajeshkumar NV, Matsui W, Brossart P, Hidalgo M, Bannerji R, Maitra A, Nelkin BD.
Feldmann G, et al.
Cancer Biol Ther. 2011 Oct 1;12(7):598-609. doi: 10.4161/cbt.12.7.16475. Epub 2011 Oct 1.
Cancer Biol Ther. 2011.
PMID: 21768779
Free PMC article.